Clinical Trial Update: Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the Human Acellular Vessel (HAV) with ePTFE grafts for hemodialysis vascular access in end-stage renal disease; the study completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Human Acellular Vessel (HAV)

Snippet

Sponsor: Humacyte, Inc. | Conditions: Renal Failure, End Stage Renal Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-03-30